RecruitingNCT01750619
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
Sponsor
California Pacific Medical Center Research Institute
Enrollment
8,000 participants
Start Date
Jul 1, 2011
Study Type
OBSERVATIONAL
Conditions
Summary
To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients age \>18 years that have been referred for endoscopic treatment of GI lesions.
Exclusion Criteria1
- Patients for whom endoscopic treatment was not performed.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01750619
Related Trials
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
NCT0721892684 locations
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
NCT066633199 locations
Impact of Oral Versus Intravenous 5-FU-Based Adjuvant Regimens on Sleep Quality and Depression in Patients With Gastrointestinal Cancers
NCT069964833 locations
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
NCT049076431 location
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
NCT0722280016 locations